Angiogenesis - still a worthwhile target for breast cancer therapy?

Por Lord, Simon, Harris, Adrian L
Publicado em 2010

Targeting glycogen metabolism: a novel strategy to inhibit cancer cell growth?

Por Favaro, Elena, Harris, Adrian L.
Publicado em 2013

Hypoxia and oxidative stress in breast cancer: Hypoxia and tumourigenesis

Por Knowles, Helen J, Harris, Adrian L
Publicado em 2001

VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor

Por Favara, David M, Harris, Adrian L
Publicado em 2014

Microenvironmental induced essentiality of autophagy

Por Singleton, Dean C., Harris, Adrian L.
Publicado no Clin Cancer Res (2013)

Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality

Por McIntyre, Alan, Harris, Adrian L
Publicado no EMBO Mol Med (2015)

Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy

Por Zois, Christos E., Harris, Adrian L.
Publicado no J Mol Med (Berl) (2016)

To branch or to expand?

Por Bridges, Esther M, Harris, Adrian L
Publicado no eLife (2016)

Hypoxia metabolism in ageing

Por Valli, Alessandro, Harris, Adrian L, Kessler, Benedikt M
Publicado no Aging (Albany NY) (2015)

Serum concentrations of sex hormone binding globulin in lung cancer

Por Dowsett, Mitchell, Pearce, Sarah, Hendrick, Alex, Harris, Adrian L
Publicado em 1986

Breast tumour angiogenesis

Por Fox, Stephen B, Generali, Daniele G, Harris, Adrian L
Publicado em 2007

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis

Por Jubb, Adrian M, Buffa, Francesca M, Harris, Adrian L
Publicado em 2010

Hypoxia response and microRNAs: no longer two separate worlds

Por Ivan, Mircea, Harris, Adrian L, Martelli, Fabio, Kulshreshtha, Ritu
Publicado em 2008

Efficacy, safety, and cost of new anticancer drugs : Pessimistic conclusion was not justified

Por Calvert, Hilary, Jodrell, Duncan I, Cassidy, James, Harris, Adrian L
Publicado em 2002

Human endothelial stem/progenitor cells, angiogenic factors and vascular repair

Por Watt, Suzanne M., Athanassopoulos, Athanasios, Harris, Adrian L., Tsaknakis, Grigorios
Publicado em 2010

Gene expression and hypoxia in breast cancer

Por Favaro, Elena, Lord, Simon, Harris, Adrian L, Buffa, Francesca M
Publicado em 2011

The Notch Ligand Jagged1 as a Target for Anti-Tumor Therapy

Por Li, Demin, Masiero, Massimo, Banham, Alison H., Harris, Adrian L.
Publicado em 2014

Differential Gene Expression Patterns in HER2/neu-Positive and -Negative Breast Cancer Cell Lines and Tissues

Por Wilson, Katherine S., Roberts, Helen, Leek, Russell, Harris, Adrian L., Geradts, Joseph
Publicado em 2002

The chemistry, physiology and pathology of pH in cancer

Por Swietach, Pawel, Vaughan-Jones, Richard D., Harris, Adrian L., Hulikova, Alzbeta
Publicado em 2014

Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells

Por Interiano, Rodrigo B., Yang, Jun, Harris, Adrian L., Davidoff, Andrew M.
Publicado em 2014